a first-generation antipsychotic of the diphenylbutylpiperidine category. Alike to other conventional antipsychotics, it is an inhibitor of postsynaptic dopamine 02 receptors. In the U.S., it is formally approved by the FDA, but just for the control of vocal and motor tics correlated with Tourette
PIMOZIDE: “The doctor prescribed Pimozide to treat my facial tics.”